中興(00763.HK)夥電信、聯通展示數字孿生5G網絡共享範例
中興通訊(00763.HK)在線上論壇上,協同中國電信(00728.HK)、中國聯通(00762.HK)以及其他合作夥伴,展示了「基於數字孿生的5G網絡共享」催化劑項目,為5G新基建下的共享共建網絡提供了構建領先的數字化運營系統的範例。
而近日中興亦率先在中國信息通信研究院、中國移動研究院聯合首創的毫米波OTA性能測試系統中,完成全球首家、基於多探頭暗室、端到端的毫米波系統性能測試。
中興通訊的毫米波基站系統,除了完整驗證了毫米波OTA系統的測試規範,亦在不同的複雜信道下,均保持著良好的端到端性能,標誌著毫米波商用系統向前邁出一大步。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.